3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Lymphoma
19
Leukemia, Myeloid, Acute
18
Myelodysplastic Syndromes
17
Lymphoma, Non-Hodgkin
14
Neoplasms, Plasma Cell
12
Leukemia
12
Neuroblastoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Large B-Cell, Diffuse
9
Hodgkin Disease
9
Recurrence
7
Melanoma
7
Lymphoma, Mantle-Cell
7
Hematologic Neoplasms
7
Burkitt Lymphoma
7
Sarcoma
6
Ovarian Neoplasms
6
Myeloproliferative Disorders
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Sarcoma, Ewing
5
Neoplasm Metastasis
5
Medulloblastoma
5
Lymphoma, B-Cell, Marginal Zone
5
Liver Neoplasms
5
Wilms Tumor
4
Rhabdomyosarcoma
4
Retinoblastoma
4
Interventions
Temozolomide
3
veliparib
1
romidepsin
1
perillyl alcohol
1
lonafarnib
1
ispinesib
1
etoposide phosphate
1
emvododstat
1
cediranib
1
Vorinostat
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Therapeutics
1
RRx-001
1
Peripheral Blood Stem Cell Transplantation
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Melphalan
1
Irinotecan
1
Infusions, Intra-Arterial
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Drug Therapy
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Calcium Dobesilate
1
CK0238273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Spinal Cord Neoplasms
×
Melphalan
×
Clear all
NCT01637766
2020-08-03
SIAC
Weill Medical College of Cornell University
Phase 1
Completed
12 enrolled